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Introduction
The gold standard method of direct measurement 
of red cell volume (RCV) and/or plasma volume 
(PV) using radioactive tracers is too elaborate1, 
expensive and invasive for incorporation into 
clinical routine. This, however, leaves physicians 
unhappy about having to make significant decisions 
involving infusion and transfusion therapy without 
robust information on their actual target. Explicit 
attempts to achieve at least an indirect estimate of 
pre-operative blood volume or RCV underline 
the strong desire for more accurate knowledge 
of quantitative blood composition2. Despite 
mounting evidence against using haemoglobin 
concentration (Hb) and haematocrit (Hct) to screen 
for hypovolaemia or determine the requirement for 
packed red cell transfusion3, physicians on wards and in 
peri-operative and intensive care settings still mainly 
resort to such practice4. These largely interchangeable 
twin surrogates have become enshrined in clinical 
Background. Although haematocrit and haemoglobin value are concentrations, they are 
commonly used to guide clinical decisions involving red cell and plasma volumes. A study 
challenging this convention systematically co-determined and compared these measures.
Materials and methods. Using a non-radioactive double-tracer technique to assess blood 
volume components, measurements were taken once in 46 healthy male endurance athletes. 
The best predictors of blood composition were derived from the first 36 athletes by automated 
stepwise forward selection of non-invasive metric parameters (age, weight, height, body surface 
area and body mass index) and the resulting formulae validated in the remaining ten volunteers. 
Haematocrit, haemoglobin concentration, red cell volume and plasma volume were measured 
again 4 weeks later in eight randomly selected volunteers.
Results. Red cell volume (2,282±283 mL) did not correlate with either haematocrit 
(0.42±0.02) or haemoglobin concentration (14.2±0.8, P>0.05, resp.), but was predictable from 
body surface area (red cell volume [mL]=1,547 x body surface area [m2]–723; r=.88, P<0.01). 
A similar accuracy was unobtainable using any potential predictor for plasma or blood volume, 
haematocrit or haemoglobin concentration. Red cell volume showed high intra-individual 
stability when measured again after 4 weeks, whereas plasma volume oscillated in both directions 
by up to 22%.
Discussion. Only red cell volume shows sufficiently stable intra- and interindividual values 
to be an accurate, objective indicator of normality in blood composition. The measurement 
technique is feasible in the outpatient setting and this parameter provides effective, robust, and 
readily available diagnostic information that might be useful in numerous clinical situations. 
Its clinical significance does, however, remain to be demonstrated.
Keywords: haematocrit, haemoglobin, red cell volume, plasma volume, endothelial surface 
layer.
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guidelines. Thus in pregnancy or postpartum, iron is 
often administered once the Hb falls below a certain 
threshold, sometimes even without the additional 
measurement of ferritin, while the World Health 
Organization has made an upper threshold of Hb 
a major diagnostic criterion in myeloproliferative 
neoplasms5. In other contexts, as the short half-life 
of erythropoiesis-stimulating agents makes the direct 
detection of blood doping difficult after more than 
2-3 days6,7, the World Anti-Doping Agency includes 
Hb and Hct among other indirect parameters of 
erythropoiesis in its screening procedures, with no 
attempt at blood component quantification8. The tacit, 
shared assumption underlying each of these protocols, 
namely that Hb and Hct are sufficiently reliable 
indicators of RCV for routine use, must be questioned.
The purpose of the present study was to challenge 
the conventional approach by assessing the ability of 
Hct and Hb to predict individual RCV and PV in a 
highly standardised population of comparably trained 
endurance athletes. We set out to test for interindividual 
constancy, i.e. predictability of RCV, PV, blood volume 
(BV), Hct, and Hb from external metric characteristics 
under steady-state conditions. In cases in which we 
found a significant correlation between the predicted 
and actual value in a first (training) subset of our 
population, we sought to validate the underlying 
automatically generated formula prospectively 
against the actual values measured in a second 
(validation) subset. Our other objectives were to test the 
intra-individual stability of quantitative blood 
composition, assess the feasibility of a well established, 
less invasive and non-radioactive alternative to the 
gold standard method of BV assessment, and discuss 
the impact of its potential introduction into routine use.
Materials and methods
The study protocol was approved by the Zurich 
cantonal institutional review board and all volunteers 
gave written informed consent to participation in the 
study. Inclusion criteria were male gender, age 18 to 45 
years, and regular amateur participation in competitive 
endurance disciplines such as cycling, swimming, 
and running for at least 3 years. The aim of setting 
these criteria was to limit intra-individual scatter 
related to gender, sickness and physical constitution 
within our sample population. Exclusion criteria 
were iron deficiency (ferritin <15 µg/L), anaemia 
(Hb <11.7 g/dL), blood transfusion in the previous 4 
months, and ongoing prescription medication.
Each subject was studied once, between 08:00 and 
10:00, except for eight randomly selected subjects 
who were studied again 4 weeks later (see below). On 
their scheduled study morning subjects were asked 
to eat their normal breakfast, omitting caffeinated 
drinks (clear fluids were allowed), and come to our 
laboratory without having exercised beforehand. On 
arrival, they reclined on an examination couch while 
a 17-gauge cannula was placed in an antecubital 
vein. Measurements were taken within 15 to 30 min 
(a minimum of 15 min in the supine position being 
observed to allow stable equilibration of body fluids).
Determination of blood components 
RCV and PV were co-determined using a 
non-radioactive, double-label technique based on 
measuring the compartmental concentrations of 
intravenously injected tracers. Distribution spaces 
were calculated from these concentrations and the 
amount of tracer injected.
Measurement of plasma volume with indocyanine 
green 
A bolus of indocyanine green (ICG, Fa. Paesel, 
Frankfurt a. M., Germany), which binds rapidly to 
plasma proteins and is eliminated exclusively by the 
liver, was injected into a peripheral vein. Given the 
dye's short half-life of about 3 min, the theoretical 
plasma concentration at the injection time has to 
be extrapolated from several timed samples taken 
after complete mixture with the plasma. From this 
concentration and the amount of dye injected the 
initial distribution space of ICG, i.e. the PV, can 
be calculated. The technical details and theoretical 
background of this method have been described 
extensively elsewhere9,10.
In brief, two 10 mL venous blood samples were 
withdrawn immediately before injecting an intravenous 
bolus of  0.25 mg/kg ICG over 5 sec at t0. Starting from 
2 min post-t0, ten 2.5 mL venous blood samples were 
taken precisely every 20 sec into lightly heparinised 
tubes and centrifuged immediately to obtain the plasma.
A two-point system calibration was performed 
by spiking the two pre-injection samples with 
known amounts of ICG. This gave two known 
plasma concentrations (1.25 and 2.5 µg/mL) whose 
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specific extinctions, due exclusively to the ICG in 
the plasma sample, were then derived by subtracting 
extinction at 900 nm (zero ICG extinction) from that 
at 805 nm (maximal ICG extinction). Thanks to the 
known linear dependency of plasma concentration 
on specific extinction, the resulting equation allowed 
concentrations to be derived from any extinction value. 
We also measured the specific extinctions of the ten 
venous plasma samples taken from each volunteer's 
circulation. ICG concentrations at t0 were derived from 
monoexponential extrapolation of the light absorption 
curve resulting from the respective measuring time 
points back to t0, assuming a one-compartment model. 
The calibration led directly to the theoretical plasma 
concentration at injection time (CP0). The PV could 
then be calculated as follows: 
PV[mL]=D[mg] x CP0−1[mg x mL−1]
D being the amount of dye injected.
Red cell volume measurement with sodium 
fluorescein 
RCV was derived by injecting a known amount of 
autologous red cells labelled with sodium fluorescein 
(Fa. Alcon, Freiburg, Germany), a non-radioactive 
marker, and determining their fraction in venous 
blood samples after recirculation11,12. A 30 mL sample 
of peripheral venous whole blood was taken from 
each volunteer to label the red blood cells. The blood 
was centrifuged and the red cell suspension incubated 
with 48 mg sodium fluorescein for 5 min. To remove 
unbound fluorescein, the cells were washed twice in 
calcium gluconate solution, and then resuspended to 
the volume of the initial blood sample (30 mL) using 
Ringer's lactate solution. The labelled red cells were 
re-infused via the peripheral cannula. Three samples 
were drawn from the peripheral cannula between 5 
and 10 min after injection, stored on ice, and analysed 
by flow cytometry (FACScan, Becton Dickinson, 
Heidelberg, Germany) using an argon laser at 488 nm.
RCV was then calculated as follows:
RCV[mL]=(Ei x Vi x HctLV)/(Ep x FEf)
where Ei=number of red cells injected per mL of labelled cell suspension, 
Vi=volume of injected cell suspension [mL], HctLV=subject's arterial 
blood Hct (measured in triplicate), Ep=number of red cells per mL in 
the subject's arterial blood (measured in triplicate), and FEf=fluorescent 
erythrocyte fraction determined by flow cytometry.
The fluorescent erythrocyte fraction determined 
by flow cytometry was the mean of all three samples, 
each counted in triplicate as the number of fluorescent 
erythrocytes in 50,000 cells. Ei and Ep were obtained 
using a cell counter (530 nm; Coulter Electronics, 
Miami, FL, USA).
Determination of haematocrit 
Hct was determined in venous blood samples 
(collected into ethylene diamine tetra-acetic 
acid-treated tubes, VacutainerTM, Becton Dickinson, 
Plymouth, UK) taken about 1 min before injecting 
ICG. The Hct was measured in triplicate by 
centrifugation (15,000 g for 4 min), without 
correction for plasma trapping. To differentiate this 
Hct from the calculated theoretical whole-body Hct 
(HctWB; see below), we refer to this measured value 
hereinafter as the large-vessel Hct (HctLV).
Further calculations 
Body surface area (BSA) was derived from body 
height (H) and body weight (W) using the formula 
of Du Bois and Du Bois13: 
BSA[m2]=0.007184 x H[cm]0.725 x W[kg]0.425.
Body mass index (BMI) was calculated using the 
standard formula:
BMI[kg/m2]=W[kg]/H[m]2.
BV was derived by adding measured values of 
PV and RCV: 
BV[mL]=PV[mL]+RCV[mL].
Mean HctWB was calculated from the RCV and BV: 
HctWB[fraction]=RCV[ml] x BV[ml]
−1.
Normally, HctWB is slightly lower than HctLV 
because of the considerable non-circulating fraction 
of PV sequestered in the endothelial surface layer 
(ESL)9, representing an exclusion zone for blood 
cells. The F-cell ratio quantifying this difference 
between the two haematocrit values was calculated 
as: 
F-cell=HctWB[fraction] x HctLV[fraction]
−1.
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The red cell distribution space was interpreted as 
the circulating fraction of PV (PVcirc). Using the red 
cells as tracer, it was calculated as14: 
PVcirc[ml]=(1–HctLV [fraction]) x RCV[mL]/
HctLV[fraction].
The total volume of the ESL, the non-circulating 
fraction of PV, was calculated as: 
ESL[mL]=PV[mL]–PVcirc[mL].
Normal RCV and PV values in male non-athletes 
were derived from BSA as recommended by the 
Expert Panel on Radionuclides of the International 
Council for Standardisation in Haematology1: 
RCVnormal[mL]=(1,486 x BSA[m
2]–825); 
PVnormal[mL]=1,578 x BSA[m
2].
Selection and testing of potential predictors of 
"normal" red cell, plasma and blood volumes 
in endurance athletes in order to screen for 
"abnormal" values
We recruited a total of 46 volunteers who we 
randomly divided into a training set (n=36) and 
a validation set (n=10). From the training set 
we randomly selected a further subgroup (n=8) 
for repeated study 4 weeks later. Our study was 
performed outside the competition period, the 
athletes were training extensively and continuously 
to maintain their condition. The eight randomly 
selected volunteers were strongly discouraged 
to change their training behaviour during the 
observation period. We used program R 2.7.1 from 
the R environment (http://www.r-project.org) to 
implement an automated stepwise forward selection 
procedure from the training set of potential metric 
predictors for RCV, PV and BV (age, weight, height, 
BSA and BMI). These parameters were readily 
available, non-invasive and, most importantly, not 
directly dependent on the blood compartments. The 
algorithm started with an empty model and evaluated 
one predictor at a time. The best predictor, giving the 
lowest P value, was added and the algorithm restarted 
with this new model, with the remaining predictors 
being added one at a time. Predictors were discarded 
if they lost statistical significance after another 
variable was added. The predictive performance of 
the resulting best formulae was assessed using the 
validation set.
Statistical analysis 
Spearman's rank correlation was used to study 
associations between two variables. A level of 
statistical significance of less than 0.05 was used 
in all tests. Data are given as the mean ±SD. All 
measured and calculated values were normally 
distributed (according to the Kolmogorov-Smirnov 
test). The Pearson's product-moment correlation 
coefficient was used to test for associations between 
continuous variables. Student's t-test was used to 
compare groups, whereas paired Student's t tests were 
used for the intra-individual follow-up at 4 weeks, 
being insensitive to possible deviations from normal 
distribution. All analyses were performed using SPSS 
18 (SPSS, Chicago, IL, USA).
Results
Table I shows the demographic data. Table II 
presents the measured and calculated results for the 
training and validation subsets. Figures 1, 2 and 
3 refer to the training set only. Hb values ranged 
widely in our population, but RCV and PV correlated 
significantly with BSA (Figure 1). Outliers were 
particularly prominent in the PV data. Although 
RCV did not correlate with either Hct or Hb, a slight 
negative relationship was observed between PV and Hb 
Jacob M et al
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Table I - The volunteers' characteristics (potential metric predictors).
Training set (n=36) Validation set (n=10)
Age, years 33±7 (20-45) 30±7 (21-45)
Height, cm 180±5 (168 -93) 177±7 (168-187)
Weight, kg 75±9 (60-100) 71±6 (64-83)
Body surface area, m2 1.94±0.13 (1.68-2.31) 1.87±0.11 (1.73-2.08)
Body mass index, kg/m2 23.1±1.9 (19.8-28.7) 22.5±0.8 (21.0-23.6)
Values are mean±SD (min-max). 
Differences between the two subsets were not statistically significant (P>0.05).
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Table II - Measured and calculated variables.
Training set (n=36) Validation set (n=10)
RCV, mL 2,282±283 (1,834-2,853) 2,093±208 (1,803-2421)
RCV, mL/m2 BSA 1,173±107 (996-1,390) 1,117±59 (1,044-1212)
RCV, mL/kg BW 30±3 (23-26) 30±1 (28-32)
PV, mL 3,739±502 (2,632-5,352) 3,528±440 (2,978-4,138)
PV, mL/m2 BSA 1,922±209 (1,500-2,500) 1,891±259 (1,566-2,191)
PV, mL/kg BW 50±6 (41-62) 50±7 (41-59)
BV, mL 6,022±712 (4,486-8,205) 5,622±511 (4,781-6,475)
BV, mL/m2 BSA 3,095±269 (2,556-3,832) 3,008±263 (2,667-3,358)
BV, mL/kg BW 80±8 (71-95) 80±8 (70-89)
Hb, g/dL 14.2±0.8 (12.9-15.8) 14.4±0.9 (12.3-15.4)
HctLV 0.42±0.02 (0.38-0.46) 0.42±0.03 (0.35-0.47)
HctWB 0.38±0.03 (0.33-0.44) 0.37±0.04 (0.33-0.43)
HctWB/HctLV 0.91±0.05 (0.78-1.00) 0.89±0.07 (0.80-1.00)
ESL, mL 517±334 (0-1,349) 604±420 (8-1,128)
Values are mean±SD (min-max).
BSA indicates body surface area; BV, blood volume (RCV + PV); BW, body weight; ESL, endothelial surface layer; 
Hb, haemoglobin concentration in peripheral blood; HctLV, large-vessel haematocrit; HctWB, whole-body haematocrit 
(RCV/BV); PV, plasma volume; RCV, red cell volume.
Differences between the two subsets were not statistically significant (P>0.05).
Figure 1 - Correlation of red cell volume (black 
squares, r=0.69, P<0.001) and plasma volume 
(white triangles, r=0.58, P<0.001) with body 
surface area using Pearson's product-moment 
correlation coefficient (training set, n=36).
Figure 2 - Correlation of red cell volume (black 
squares, P>0.05) and plasma volume (white 
triangles, r=0.35, P<0.05) with haemoglobin 
concentration using Pearson's product-moment 
correlation coefficient (training set, n=36).
(Figure 2). The results confirmed the expected 
dependence of HctLV on Hb (Figure 3). In the 36 
athletes in the training set RCV was only slightly, if 
significantly, increased over the normal adult range1 
(2,282±283 vs. 2,063±186 mL, P<0.001), whereas PV 
and BV were both considerably increased1 (3,739±502 
vs. 3,067±198 mL and 6,022±712 vs. 5,130±384 mL, 
both P<0.001).
The mean overall study time per volunteer (n=46) 
from couch to cannula removal was 49±2 min.
Stepwise forward selection of potential external 
metric predictors (Table I) of measured Hb and Hct 
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Figure 4 - Correlation between measured red cell volume and 
that predicted using a formula derived from the 
training set (n=36) in a new validation set (n=10, 
r=0.88, P<0.01). Dotted line=line of equality.
Figure 5 - Intra-individual changes in red cell volume 
(RCV, diamonds) and plasma volume (PV, 
triangles) measured on two occasions 4 weeks 
apart in eight patients randomly selected from 
the training set.
Figure 3 - Correlation of large-vessel haematocrit with 
haemoglobin concentration using Pearson's 
product-moment correlation coefficient (r=0.85, 
P<0.001) (training set, n=36).
showed no correlation in the training set, while RCV, 
PV and BV values generated the following formulae: 
RCV[mL]=1,547 x BSA[m2]–723 (r=0.68, P<0.01); 
PV[mL]=2,312 x BSA[m2]–754 (r=0.56, P<0.01); 
and 
BV[mL]=3,859xBSA[m2]–1477 (r=0.67, P<0.01).
Applying these calculations to the measurements 
made in the validation set (n=10) in order to assess 
their generalisability and predictive performance 
showed that only the predicted RCV value correlated 
significantly with the measured value (r=0.88, P<0.01 
[Figure 4]). P values for PV and BV were 0.99 and 
0.28 (not shown).
Follow-up of eight patients randomly selected 
from the training set showed no significant overall 
changes after 4 weeks in mean RCV, PV, HctLV, or 
total ESL volume (2,229±300 mL vs. 2,240±311 
mL; 3,763±852 mL vs. 3,749±642 mL; 0.42±0.03 
vs. 0.42±0.01; and 609±320 mL vs. 634±431 mL; all 
P>0.05, Figures 5-7). Intra-individual RCV proved 
highly stable, with a mean difference of 53±47 mL 
(maximum: 119 mL, equivalent to only 5%), whereas 
PV changed unpredictably in both directions by up 
to 1,054 mL (22%; mean 404±332 mL; Figure 5). 
This was related to antidromic individual changes 
in Hct of up to 0.03 (8%; the mean intraindividual 
difference was 0.02±0.01; Figure 6). Total ESL 
volume fluctuated intra-individually by up to 769 
mL (82%; the mean intra-individual difference was 
280±236 mL; Figure 7), for no detectable reason.
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Discussion
Hct and Hb represent, by definition, the 
oxygen-carrying capacity of the blood. Therefore, 
the common therapeutic strategy to transfuse red 
cells into a given blood volume to increase their 
concentration appears, at first view, quite reasonable. 
Unfortunately, it is clearly based on an assumption 
that is often not fulfilled: a "normal" and constant PV.
Our data contradict the generally assumed 
correlation between RCV and Hct or Hb in peripheral 
blood vessels, even for fluid compartments in steady 
state. The reason is primarily mathematical: the 
concentration values are inversely related to total 
distribution space volume. The RCV in the circulation 
represents total oxygen-binding capacity, while PV 
is the non-corpuscular fraction of the blood, mainly 
responsible for cardiac preload and rheology. It 
follows that Hct is not a purely red cell parameter: it 
does indeed change with RCV, but it also decreases 
with an increasing PV and vice versa, as borne out 
by the slight negative association with PV in our 
study. Unlike inter- and intra-individually stable 
RCV, which our data show to be reliably predictable 
from BSA, PV is a short-term variable, changing 
intra-individually within seconds due to body 
position, coughing etc15. Standing, for instance, 
elevates Hct, due to raised hydrostatic pressure in the 
lower limb venous system force-filtering plasma into 
tissue, as opposed to the situation when a subject is 
sitting or lying down16. 
A second serious conceptual limitation to the current 
practice of extrapolating RCV from peripheral blood 
Hct and Hb is the inter- and intra-individual variability 
in total ESL volume9.This recently described red cell 
exclusion zone on the luminal surface of the endothelial 
cell layer consists of membrane-bound glycoproteins 
and proteoglycans that bind plasma constituents by 
virtue of special charge properties17. An intact ESL 
makes a significant contribution to vascular barrier 
competence18 while also mediating other important 
physiological functions such as anti-inflammation 
and shear-stress transduction to the endothelial 
surface19. As confirmed by the present study, this 
non-circulating fraction of PV normally exceeds 0.5 
L in adults14. Intra-individually it is positively related 
to the peripheral red cell concentration and, therefore, 
to Hb and Hct.  The smaller the ESL, the more red 
cells are able to hide within the microcirculation, 
artificially decreasing the apparent Hb concentration 
and peripheral venous Hct. The opposite effects occur 
for a larger ESL. There are no external markers for 
predicting intra-individual variability in total ESL 
volume. For this reason it is erroneous to calculate 
BV from RCV or PV and peripheral Hct, despite 
the repeated attempts to do so20, since the error 
can be as high as 20%. While the demonstrated 
Haematocrit: a poor estimate of red cell volume
Blood Transfus 2012; 10: 471-9  DOI 10.2450/2012.0111-11
Figure 6 - Intra-individual changes in haematocrit 
measured on two occasions 4 weeks apart 
in eight patients randomly selected from the 
training set.
Figure 7 - Intra-individual changes in total endothelial 
surface layer volume measured on two occasions 
4 weeks apart in eight patients randomly selected 
from the training set.
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intra-individual oscillations in the total volume of this 
physiologically crucial structure should not have any 
clinical impact beyond our mathematical calculations 
it has repeatedly been demonstrated that this might not 
be the case in critical illness. In particular, the release 
of inflammatory mediators due to trauma, sepsis and 
ischaemia/reperfusion, but also of atrial natriuretic 
peptide during artificial intravenous volume loading 
caused a significant destruction of the ESL in humans. 
This led to protein extravasation and tissue oedema, 
loss of nutritional blood flow, and an increase in platelet 
and leucocyte adhesion and, in septic shock, was 
strongly related to overall mortality21. ESL protection 
will be an important issue with great potential in future 
intensive care medicine. Already today, anaesthetists 
increasingly try to avoid intravascular hypervolaemia 
by applying rational, target-oriented fluid management 
during major surgical interventions22.
Our data show that in a given subject it is just as 
inappropriate to assume that the RCV is abnormal 
on the basis of Hct and Hb values outside the 
normal range as it is to discount an abnormal RCV 
on the basis of a normal Hct and Hb: these are 
randomly influenced variables with no acceptable 
inter-individual normal value. Nevertheless, as being 
responsible for an adequate oxygen delivery to the 
cells, together with cardiac output, a decrease in 
these concentration measures below the individual 
"transfusion trigger" requires immediate correction. 
As it could in fact indicate the normally assumed real 
decrease in RCV due to acute bleeding, transfusing 
packed red cells might often be the correct treatment of 
a decreased Hb value. However, an increase in PV by 
inappropriate infusion therapy leading to hypervolaemia 
of the extracellular space could also present like this, 
with a causal therapy keeping the organism in balance 
being the use of diuretics in this case. Only direct 
measurement of the RCV is methodologically safe, free 
from any contestation and actually helpful.
Considerable efforts have been made to the 
retrospective generation of predictive formulae for 
RCV and PV from metric parameters in a given 
population and, thereby, establishing individual normal 
values1. However, to the best of our knowledge, our 
study is the first to have also prospectively evaluated 
predictive performance in a second independent 
subset. While our training set suggested that PV would 
prove highly predictable, as previously reported1, the 
formula proved invalid in the subsequent validation 
set. This demonstrated that intra-individual prediction 
of PV, as of the related red cell concentration, is 
unreliable, thus reconfirming our previous point.
The observation that endurance athletes might have 
a slightly higher PV than the normal population is 
interesting. It illustrates the changes in blood composition 
behind the well-known pseudo-anaemia consistently 
diagnosed in this population on the basis of a decrease in 
peripheral Hct23. This was not, however, a central focus 
of our study, which was primarily methodological. 
Our non-radioactive technique not only deepens 
understanding of a significant practical problem in 
various clinical fields, but it also provides a possible 
solution. Previous clinical studies9,11,24 have already 
shown that the non-radioactive techniques used here to 
assess RCV and PV directly provide a reliable, accurate 
and precise alternative to the gold standard1, delivering 
the desired information within less than 1 hour. It has 
been frequently applied scientifically to patients and 
volunteers in the past and helped to answer important 
clinical questions14,25-28. Measurements are performed 
using the same single peripheral cannula required for 
conventional and clearly inferior screening techniques. 
As for RCV, comparable efforts have been made in 
the past to determine Hb mass by carbon monoxide 
rebreathing studies29-31. This scientifically well-
established method is indeed convenient and virtually 
bloodless. However, the information concerning total 
BV gained from this test lacks precision because the 
RCV can only be estimated from an Hb mass and total 
PV cannot reliably be calculated from RCV and Hct, 
for the reasons set out earlier.
Given its proven feasibility, this currently largely 
academic procedure for simultaneously measuring 
RCV and PV could find its way into routine clinical 
use for selected indications when the physician needs 
accurate information on the amount of circulating 
red cells. The clinical significance for patients' 
outcome and the cost-benefit ratio of this in principle 
undoubtedly useful additional information do, 
however, remain to be determined.
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